F. B. Cakir Et Al. , "IRF4 Positivity is a Novel Diagnostic and Prognostic Marker for Diffuse Large B Cell Lymphoma," PEDIATRIC BLOOD & CANCER , vol.65, 2018
Cakir, F. B. Et Al. 2018. IRF4 Positivity is a Novel Diagnostic and Prognostic Marker for Diffuse Large B Cell Lymphoma. PEDIATRIC BLOOD & CANCER , vol.65 .
Cakir, F. B., Guler, B., Cay, A., Mirapoglu, S., Turkmen, A. V., & Aki, H., (2018). IRF4 Positivity is a Novel Diagnostic and Prognostic Marker for Diffuse Large B Cell Lymphoma. PEDIATRIC BLOOD & CANCER , vol.65.
Cakir, F. Et Al. "IRF4 Positivity is a Novel Diagnostic and Prognostic Marker for Diffuse Large B Cell Lymphoma," PEDIATRIC BLOOD & CANCER , vol.65, 2018
Cakir, F. B. Et Al. "IRF4 Positivity is a Novel Diagnostic and Prognostic Marker for Diffuse Large B Cell Lymphoma." PEDIATRIC BLOOD & CANCER , vol.65, 2018
Cakir, F. B. Et Al. (2018) . "IRF4 Positivity is a Novel Diagnostic and Prognostic Marker for Diffuse Large B Cell Lymphoma." PEDIATRIC BLOOD & CANCER , vol.65.
@article{article, author={F. B. Cakir Et Al. }, title={IRF4 Positivity is a Novel Diagnostic and Prognostic Marker for Diffuse Large B Cell Lymphoma}, journal={PEDIATRIC BLOOD & CANCER}, year=2018}